Targeting Frailty in Heart Failure

Current Treatment Options in Cardiovascular Medicine

Volumn 19, Issue 4, 2017, Pages

  Joseph, Susan M ^a   Rich, Michael W ^b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Frailty; Fried criteria; Heart failure; Multimorbidity; Sarcopenia

Indexed keywords

CYTOKINE; STRESS HORMONE;

AGING; DIET SUPPLEMENTATION; DISABILITY; EXERCISE; FRAILTY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORBIDITY; PROGNOSIS; REVIEW; STRENGTH;

EID: 85016428368     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-017-0527-5     Document Type: Review

References (48)

1. •• Joyce E. Frailty in advanced heart failure. Heart Fail Clin [Internet]. 2016 [cited 2016 Nov 19];12:363–74. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1551713616300253. This paper is a detailed and well-written review of currently published work on frailty in HF.
2. Loncar G, Springer J, Anker M, Doehner W, Lainscak M. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle [Internet]. 2016 [cited 2016 Nov 19];7:246–60. Available from: http://doi.wiley.com/10.1002/jcsm.12118
3. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683–93.
4. • Flint KM, Matlock DD, Lindenfeld J, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012 Mar 1;5(2):286-93. This paper gives a great framework on the complexities in decision making when assessing patients for DT-LVAD for the frailty syndrome and provides a comprehensive review of the medical literature.
5. Panza F, Solfrizzi V, Frisardi V, Maggi S, Sancarlo D, et al. Different models of frailty in predementia and dementia syndromes. J Nutr Health Aging [Internet]. 2011 [cited 2016 Nov 19];15:711–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21968870
6. De Vries NM, Staal JB, Van Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev. 2010;10:104–14.
7. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, et al. Frailty in older adults: evidence for a phenotype. Journals Gerontol Ser A Biol Sci Med Sci [Internet]. 2001 [cited 2016 Nov 19];56:M146–57. Available from: http://biomedgerontology.oxfordjournals.org/cgi/doi/10.1093/gerona/56.3.M146
8. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, et al. The cardiovascular health study: design and rationale. Ann Epidemiol [Internet]. 1991 [cited 2016 Nov 19];1:263–76. Available from: http://linkinghub.elsevier.com/retrieve/pii/104727979190005W
9. Dunlay SM, Park SJ, Joyce LD, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Hear Lung Transplant. 2014;33:359–65.
10. Heberton GA, Nassif M, Bierhals A, Novak E, Larue SJ, et al. Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2016 [cited 2016 Nov 1];118(9):1363-7.
11. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–8.
12. Lee JS-J, He K, Harbaugh CM, Schaubel DE, Sonnenday CJ, et al. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg [Internet]. 2011;53:912–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21215580
13. Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg [Internet]. 2012;16:1478–86. Available from: http://dx.doi.org/10.1007/s11605-012-1923-5
14. Sheetz KH, Zhao L, Holcombe SA, et al. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer. Dis Esophagus. 2013;26:716–22.
15. Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, et al. The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator. Europace. 2015;17:598–602.
16. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. 2014.
17. Chaudhry SI, McAvay G, Chen S, Whitson H, Newman AB, et al. Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study. J Am Coll Cardiol [Internet]. 2013 [cited 2016 Nov 19];61:635–42. Available from: http://www.sciencedirect.com/science/article/pii/S0735109712056689
18. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation [Internet]. 2014;129:e28–292. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24352519
19. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association [Internet]. 2015. Available from: http://circ.ahajournals.org/cgi/doi/10.1161/CIR.0000000000000152
20. Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005;35:723–30.
21. McNallan SM, Singh M, Chamberlain AM, Kane RL, Dunlay SM, et al. Frailty and healthcare utilization among patients with heart failure in the community. JACC Hear Fail [Internet]. 2013 [cited 2016 Nov 22];1:135–41. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2213177913000565
22. Madan SA, Fida N, Barman P, et al. Frailty assessment in advanced heart failure. J Card Fail. 2016;22:840–4.
23. Lupón J, González B, Santaeugenia S, Altimir S, Urrutia A, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Española Cardiol (English Ed) [Internet]. 2008;61:835–42. Available from: http://www.sciencedirect.com/science/article/pii/S1885585708602315
24. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol. 2009;103:1616–21.
25. Pilotto A, Sancarlo D, Panza F, Paris F, D’Onofrio G, et al. Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Hear Fail [Internet]. 2010;3:191–9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863295&tool=pmcentrez&rendertype=abstract
26. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant [Internet]. 2015 [cited 2016 Nov 22];34:1495–504. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26520247
27. Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation [Internet]. 2010;121:973–8. Available from: http://circ.ahajournals.org/content/121/8/973.full.pdf
28. Arnold SV, Afilalo J, Spertus JA, Tang Y, Baron SJ, et al. Prediction of poor outcome after transcatheter aortic valve replacement. J Am Coll Cardiol [Internet]. 2016 [cited 2016 Nov 22];68:1868–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27765189
29. Kirklin JK, Naftel DC, Kormos RL, et al. The fourth INTERMACS annual report: 4,000 implants and counting. J Hear Lung Transplant. 2012;31:117–26.
30. Matthews JC, Pagani FD, Haft JW, et al. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation. 2010;121:214–20.
31. Cowger J, Sundareswaran K, Rogers JG, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices the HeartMate II risk score. 2013.
32. Chung CJ, Wu C, Jones M, et al. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. 2014.
33. Jha SR, Med Sci B, Hannu MK, et al. The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation. Transplantation. 2016;100:429–36.
34. Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Hear Fail [Internet]. 2010;12:706–15. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20494922
35. Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, et al. Effects of exercise training on health status in patients with chronic heart failure. JAMA [Internet]. 2009 [cited 2016 Nov 19];301:1451. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2009.457
36. Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, et al. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev. 2010 Apr 14;(4):CD003331.
37. Theou O, Stathokostas L, Roland KP, Jakobi JM, Patterson C, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res [Internet]. 2011 [cited 2016 Dec 10];2011:569194. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21584244
38. Cameron ID, Fairhall N, Langron C, Lockwood K, Monaghan N, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med [Internet]. 2013 [cited 2016 Nov 19];11:65. Available from: http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-65
39. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab [Internet]. 2012 [cited 2016 Dec 10];97:2670–81. Available from: http://press.endocrine.org/doi/10.1210/jc.2011-3328
40. Morley MBJE, Vellas B, Abellan van Kan G, et al. Frailty consensus: a call to action. 2013.
41. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, et al. The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab [Internet]. 2011 [cited 2016 Dec 10];96:2997–3006. Available from: http://press.endocrine.org/doi/10.1210/jc.2011-1193
42. Bischoff-Ferrari HA, Willett WC, Orav EJ, Oray EJ, Lips P, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med [Internet]. 2012 [cited 2016 Dec 10];367:40–9. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1109617
43. Morley JE, Vellas B, Abellan van Kan G, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.
44. Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, et al. Testosterone supplementation in heart failure clinical perspective. Circ Hear Fail. 2012 May 1;5(3):315-21.
45. von Haehling S. The wasting continuum in heart failure: from sarcopenia to cachexia. Proc Nutr Soc [Internet]. 2015 [cited 2016 Nov 19];74:367–77. Available from: http://www.journals.cambridge.org/abstract_S0029665115002438
46. Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane database Syst Rev [Internet]. 2009 [cited 2016 Dec 10];CD003288. Available from: http://doi.wiley.com/10.1002/14651858.CD003288.pub3
47. Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, et al. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail [Internet]. 2016 [cited 2016 Nov 19];18:869–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27072307
48. McNallan SM, Chamberlain AM, Gerber Y, Singh M, Kane RL, et al. Measuring frailty in heart failure: a community perspective. Am Heart J [Internet]. 2013 [cited 2016 Nov 22];166:768–74. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0002870313004468